JP2013532658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532658A5 JP2013532658A5 JP2013520785A JP2013520785A JP2013532658A5 JP 2013532658 A5 JP2013532658 A5 JP 2013532658A5 JP 2013520785 A JP2013520785 A JP 2013520785A JP 2013520785 A JP2013520785 A JP 2013520785A JP 2013532658 A5 JP2013532658 A5 JP 2013532658A5
- Authority
- JP
- Japan
- Prior art keywords
- glyburide
- administration
- continuous infusion
- medicament
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004580 glibenclamide Drugs 0.000 claims 77
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 77
- 238000001802 infusion Methods 0.000 claims 36
- 239000003814 drug Substances 0.000 claims 34
- 238000011010 flushing procedure Methods 0.000 claims 9
- 208000028867 ischemia Diseases 0.000 claims 6
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 206010021143 Hypoxia Diseases 0.000 claims 3
- 208000006011 Stroke Diseases 0.000 claims 3
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 3
- 206010047281 Ventricular arrhythmia Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000006378 damage Effects 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000007954 hypoxia Effects 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 208000037906 ischaemic injury Diseases 0.000 claims 3
- 208000010125 myocardial infarction Diseases 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 230000007170 pathology Effects 0.000 claims 3
- 239000004800 polyvinyl chloride Substances 0.000 claims 3
- 230000035939 shock Effects 0.000 claims 3
- 208000020431 spinal cord injury Diseases 0.000 claims 3
- 230000009529 traumatic brain injury Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- -1 polyethylene Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36568910P | 2010-07-19 | 2010-07-19 | |
| US61/365,689 | 2010-07-19 | ||
| PCT/US2011/044397 WO2012012347A2 (en) | 2010-07-19 | 2011-07-18 | Methods of intravenous administration of glyburide and other drugs |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015212868A Division JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Division JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532658A JP2013532658A (ja) | 2013-08-19 |
| JP2013532658A5 true JP2013532658A5 (https=) | 2015-05-28 |
| JP6188021B2 JP6188021B2 (ja) | 2017-08-30 |
Family
ID=45497399
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520785A Active JP6188021B2 (ja) | 2010-07-19 | 2011-07-18 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2015212868A Active JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Active JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2018230763A Active JP6795571B2 (ja) | 2010-07-19 | 2018-12-10 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2020019464A Pending JP2020073595A (ja) | 2010-07-19 | 2020-02-07 | グリブリドおよび他の薬剤の静脈内投与方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015212868A Active JP6179574B2 (ja) | 2010-07-19 | 2015-10-29 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2017051153A Active JP6506335B2 (ja) | 2010-07-19 | 2017-03-16 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2018230763A Active JP6795571B2 (ja) | 2010-07-19 | 2018-12-10 | グリブリドおよび他の薬剤の静脈内投与方法 |
| JP2020019464A Pending JP2020073595A (ja) | 2010-07-19 | 2020-02-07 | グリブリドおよび他の薬剤の静脈内投与方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (9) | US8946293B2 (https=) |
| EP (3) | EP3586850A1 (https=) |
| JP (5) | JP6188021B2 (https=) |
| KR (8) | KR20190031592A (https=) |
| CN (2) | CN103108637B (https=) |
| CA (3) | CA3101711C (https=) |
| WO (1) | WO2012012347A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102481271A (zh) | 2009-05-11 | 2012-05-30 | 博格生物系统有限责任公司 | 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法 |
| KR20190031592A (ko) | 2010-07-19 | 2019-03-26 | 바이오젠 체사피크 엘엘씨 | 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법 |
| LT2616064T (lt) | 2010-10-21 | 2019-11-25 | Rtu Pharmaceuticals Llc | Parengtos naudoti ketorolako kompozicijos |
| CA2832324C (en) | 2011-04-04 | 2022-03-15 | Berg Llc | Methods of treating central nervous system tumors |
| WO2013169939A2 (en) | 2012-05-08 | 2013-11-14 | Aeromics, Llc | New methods |
| NZ713868A (en) | 2013-04-08 | 2021-12-24 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
| KR102370843B1 (ko) * | 2013-09-04 | 2022-03-04 | 버그 엘엘씨 | 코엔자임 q10의 연속주입에 의한 암치료 방법 |
| US20160279155A1 (en) | 2013-11-06 | 2016-09-29 | Aeromics, Inc. | Novel formulations |
| US10900040B2 (en) | 2015-05-29 | 2021-01-26 | University Of Maryland, Baltimore | Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells |
| WO2017062765A1 (en) * | 2015-10-07 | 2017-04-13 | Remedy Pharmaceuticals, Inc. | Methods of treating injuries or conditions related to cns edema |
| WO2017087576A1 (en) | 2015-11-16 | 2017-05-26 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| CN109689037B (zh) | 2016-07-29 | 2022-09-13 | 生物切萨皮克有限责任公司 | 利用sur1-trpm4通道抑制剂的医学治疗方法 |
| US11382881B2 (en) | 2017-05-05 | 2022-07-12 | Nino Sorgente | Methods and compositions for diagnosing and treating glaucoma |
| WO2018204721A1 (en) | 2017-05-05 | 2018-11-08 | Nino Sorgente | Methods and compositions for improving eye health |
| CN108078999B (zh) * | 2017-12-22 | 2020-08-14 | 沈阳药科大学 | 用于防治缺血性脑卒中的药物组合物及其制备方法和用途 |
| CN115836050B (zh) | 2020-07-17 | 2024-12-20 | 上海森辉医药有限公司 | 磺酰脲类衍生物及其医药用途 |
| US12251388B1 (en) | 2024-05-09 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
| US12251389B1 (en) | 2024-04-22 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856360A (en) * | 1996-05-03 | 1999-01-05 | Children's Hospital Medical Center | Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock |
| DE10300323A1 (de) * | 2003-01-09 | 2004-10-14 | Baxter Healthcare S.A. | Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung |
| US20080220441A1 (en) * | 2001-05-16 | 2008-09-11 | Birnbaum Eva R | Advanced drug development and manufacturing |
| EP2438913B1 (en) | 2002-03-20 | 2020-05-06 | University of Maryland, Baltimore | A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling |
| US8980952B2 (en) * | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| US20040073192A1 (en) * | 2002-10-15 | 2004-04-15 | Flament-Garcia Mary Jane | Intravenous fluid delivery set |
| US20050148928A1 (en) * | 2003-12-31 | 2005-07-07 | Medtronic Minimed, Inc. | Multiple layer tubing and method of making same |
| AU2005245240B2 (en) * | 2004-05-20 | 2010-04-29 | Scimar Ltd. | Use of drug combinations for treating insulin resistance |
| EP1802313B1 (en) * | 2004-09-18 | 2010-11-03 | University of Maryland, Baltimore | Therapeutic agents trageting the ncca-atp channel and methods of use thereof |
| JP5085326B2 (ja) * | 2004-09-18 | 2012-11-28 | ユニバーシティ オブ メリーランド，ボルチモア | ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法 |
| AU2005322136B2 (en) * | 2004-12-23 | 2011-01-06 | Hospira, Inc. | Port closure system for intravenous fluid container |
| BRPI0715279A2 (pt) | 2006-09-29 | 2013-06-11 | Infa Sa | sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos |
| CA2691199C (en) * | 2007-06-22 | 2017-09-12 | Marc J. Simard | Inhibitors of ncca-atp channels for therapy |
| US20110034560A1 (en) * | 2008-01-29 | 2011-02-10 | Sven Jacobson | Liquid formulations of compounds active at sulfonylurea receptors |
| CN101229316B (zh) * | 2008-01-31 | 2010-08-25 | 广东药学院 | 一种知母提取物 |
| KR20190031592A (ko) | 2010-07-19 | 2019-03-26 | 바이오젠 체사피크 엘엘씨 | 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법 |
-
2011
- 2011-07-18 KR KR1020197007606A patent/KR20190031592A/ko not_active Ceased
- 2011-07-18 EP EP19178203.6A patent/EP3586850A1/en active Pending
- 2011-07-18 CA CA3101711A patent/CA3101711C/en active Active
- 2011-07-18 WO PCT/US2011/044397 patent/WO2012012347A2/en not_active Ceased
- 2011-07-18 KR KR1020207012483A patent/KR20200054319A/ko not_active Ceased
- 2011-07-18 KR KR1020187032015A patent/KR20180123176A/ko not_active Ceased
- 2011-07-18 JP JP2013520785A patent/JP6188021B2/ja active Active
- 2011-07-18 EP EP18157269.4A patent/EP3339190A1/en not_active Ceased
- 2011-07-18 CN CN201180044843.6A patent/CN103108637B/zh active Active
- 2011-07-18 EP EP11810231.8A patent/EP2595633A4/en not_active Ceased
- 2011-07-18 KR KR1020217042532A patent/KR20220000943A/ko not_active Ceased
- 2011-07-18 KR KR1020137004062A patent/KR20130133165A/ko not_active Ceased
- 2011-07-18 KR KR1020257005414A patent/KR20250026419A/ko not_active Ceased
- 2011-07-18 US US13/811,037 patent/US8946293B2/en active Active
- 2011-07-18 CA CA3225438A patent/CA3225438A1/en active Pending
- 2011-07-18 KR KR1020237040323A patent/KR20230165363A/ko not_active Ceased
- 2011-07-18 CN CN201810945946.3A patent/CN109172363A/zh active Pending
- 2011-07-18 KR KR1020177029156A patent/KR101917975B1/ko active Active
- 2011-07-18 CA CA2806069A patent/CA2806069C/en active Active
-
2014
- 2014-10-28 US US14/525,992 patent/US9254259B2/en active Active
-
2015
- 2015-10-08 US US14/878,232 patent/US9561176B2/en active Active
- 2015-10-29 JP JP2015212868A patent/JP6179574B2/ja active Active
-
2017
- 2017-02-06 US US15/425,874 patent/US10052280B2/en active Active
- 2017-03-16 JP JP2017051153A patent/JP6506335B2/ja active Active
- 2017-08-25 US US15/686,989 patent/US10391053B2/en active Active
-
2018
- 2018-12-10 JP JP2018230763A patent/JP6795571B2/ja active Active
-
2019
- 2019-07-02 US US16/459,893 patent/US10786445B2/en active Active
-
2020
- 2020-02-07 JP JP2020019464A patent/JP2020073595A/ja active Pending
- 2020-09-24 US US17/030,925 patent/US11559481B2/en active Active
-
2023
- 2023-01-20 US US18/157,302 patent/US12226521B2/en active Active
-
2025
- 2025-01-09 US US19/015,309 patent/US20250221924A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532658A5 (https=) | ||
| JP6795571B2 (ja) | グリブリドおよび他の薬剤の静脈内投与方法 | |
| US11498959B2 (en) | Anti-CGRP antibody formulation | |
| ES2762250T5 (es) | Tratamiento combinado del cáncer | |
| Doepker et al. | High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and beta-blocker overdose: a case series | |
| JP2017031213A5 (https=) | ||
| JP2014528474A5 (https=) | ||
| JP2013541583A5 (https=) | ||
| JP2010523714A5 (https=) | ||
| JP2023120445A (ja) | テルリプレシン組成物およびその使用方法 | |
| JP2019517542A5 (https=) | ||
| JP2014524480A5 (https=) | ||
| JP2012525393A5 (https=) | ||
| JP2016539921A5 (https=) | ||
| JP2018531938A5 (https=) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2018513188A5 (https=) | ||
| JP2016527202A5 (https=) | ||
| RU2019134416A (ru) | Фармацевтические композиции | |
| JP2014511365A5 (https=) | ||
| JP2014510782A5 (https=) | ||
| JP2020510043A5 (https=) | ||
| JPWO2021045159A5 (https=) | ||
| JP2022514152A5 (https=) | ||
| JP2006514681A5 (https=) |